Event-Driven Stocks

NRC HEALTH

NRCNasdaq

Industrials · Services-Commercial Physical & Biological Research · DE · SEC filings ↗ · Compare ⊕

View price & chart on Yahoo Finance ↗
Signs● 4 good● 2 warning● 1 severedetails ↓

Financials

SEC XBRL · annual
 FY25FY24FY23FY22FY21FY20
Revenue$137.4M$143.1M$148.6M$151.6M$148.0M$133.3M
Operating income$22.6M$35.2M$40.0M$46.5M$50.3M$42.7M
Net income$11.6M$24.8M$31.0M$31.8M$37.5M$37.3M
Total assets$134.9M$132.5M$122.4M$130.5M$157.5M$133.4M
Total liabilities$120.9M$101.3M$73.5M$58.4M$72.2M$69.1M
Equity$14.0M$31.3M$49.0M$72.0M$85.3M$64.3M
EPS (diluted)$50.00$1.04$1.25$1.27$1.46$1.45
Shares out.22.9M23.9M24.6M25.2M25.4M25.0M

Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.

Key ratios

from filings · FY2025
Operating margin
16.4%
Net margin
8.4%
Return on equity
82.9%
Return on assets
8.6%
Return on capital (ROCE)
23.0%
Liabilities / assets
89.6%
Debt / equity
8.64×
Book value / share
$0.61
Revenue growth (YoY)
−4.0%
Net income growth (YoY)
−53.2%

Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.

Financial health

forensic scores · FY2025
Altman Z″ (distress)
0.03distress
Accruals / assets
−11.0%clean
Piotroski F-Score
5/9mixed

Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.

Quality score

EDS Score
58
/ 100
Profitability 100Growth 0Catalyst 67Earnings quality 100Financial strength 25

Our own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.

Signs

● 1 severe● 2 warning● 4 good
  • Altman Z″ in the distress zone
  • Revenue declined year-over-year
  • High leverage (liabilities > 70% of assets)
  • Operating margin is positive
  • Strong return on equity (>15%)
  • Positive operating cash flow
  • Clean earnings (low accruals)

Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.

5%+ owners

SEC Schedule 13D / 13G · last 3 yrs

Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.

Short interest

FINRA · bi-monthly
SettlementShares shortDays to coverΔ vs prior
May 15, 2026456,7393.8+3.6%
Apr 30, 2026440,7125.5+4.2%
Apr 15, 2026423,0696.5-2.8%
Mar 31, 2026435,2394.8+1.9%
Mar 13, 2026427,0763.0-4.5%

Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.

Material events

SEC Form 8-K · most recent

Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.

Recent SEC filings

All filings ↗

Event-driven situations (2)

Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.